Skip to main content
. 2019 Dec 20;64(1):e01717-19. doi: 10.1128/AAC.01717-19

FIG 1.

FIG 1

Fold change (FC) dolutegravir (DTG), bictegravir (BIC), and cabotegravir (CAB) susceptibility values stratified by exposure to DTG (A), exposure to RAL only or EVG only (B), and mutational pathway (C). ns, P value not significant; **, P = 0.005.